IR@PKUHSC  > 北京大学第一临床医学院  > 感染疾病科
学科主题临床医学
Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China
Bai Li1; Feng Zhen-ru2; Lu Hai-ying1; Li Wen-gang1; Yu Min1; Xu Xiao-yuan1
关键词hepatitis C, chronic autoantibodies hepatitis, autoimmune
刊名CHINESE MEDICAL JOURNAL
2009-01-05
DOI10.3760/cma.j.issn.0366-6999.2009.01.002
122期:1页:5-9
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]ORGAN-SPECIFIC AUTOANTIBODIES ; AUTOIMMUNE HEPATITIS ; VIRUS-INFECTION ; GENERAL-POPULATION ; DISEASE ; THERAPY ; HCV ; INTERFERON ; FREQUENCY ; CHILDREN
英文摘要

Background Hepatitis C virus (HCV) infection may induce autoimmune response and autoantibodies can be detected in chronic hepatitis C (CHC) patients. However, the reported positive rate of autoantibodies in CHC patients in China varies considerably. In this study, we investigated the prevalence of antinuclear antibodies (ANA) and anti-liver-kidney-microsome type 1 autoantibodies (anti-LKM-1) in a large cohort of CHC patients, and analyzed the factors related to the presence of the autoantibodies.

Methods A total of 360 CHC patients were enrolled in this study. Serum ANA and anti-LKM-1 were detected by indirect immunofluorescence and enzyme-linked immunosorbent assay, respectively. Clinical analysis was performed to disclose the related factors to autoantibody production.

Results The prevalence of ANA and anti-LKM-1 in CHC patients was 12.5% (45/360) and 2.5% (9/360), respectively. Women had a higher prevalence than men (18.9% vs 11.4%, P=0.046). Patients with positive autoantibodies had lower HCV RNA levels (1.2x10(7) copies/L vs 7.2x10(7) Copies/L, P < 0.05). Positive ANA was associated with higher serum globulin (P < 0.05). Stratified analysis showed that there were no significant differences in age, HCV genotype, disease course, clinical stage, prevalence of cirrhosis and interferon therapy between autoantibody-positive and -negative subgroups.

Conclusion Autoantibodies can be induced in the course of CHC, and some CHC patients can even develop autoimmune hepatitis.

语种英语
WOS记录号WOS:000262693100002
项目编号2004BA7181310
资助机构National Tenth Five-Year Key Project of Science and Technology of China
引用统计
被引频次:20[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62374
专题北京大学第一临床医学院_感染疾病科
北京大学第一临床医学院_检验科
作者单位1.Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100034, Peoples R China
2.Peking Univ, Hosp 1, Dept Clin Lab, Beijing 100034, Peoples R China
推荐引用方式
GB/T 7714
Bai Li,Feng Zhen-ru,Lu Hai-ying,et al. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China[J]. CHINESE MEDICAL JOURNAL,2009,122(1):5-9.
APA Bai Li,Feng Zhen-ru,Lu Hai-ying,Li Wen-gang,Yu Min,&Xu Xiao-yuan.(2009).Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.CHINESE MEDICAL JOURNAL,122(1),5-9.
MLA Bai Li,et al."Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China".CHINESE MEDICAL JOURNAL 122.1(2009):5-9.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Bai Li]的文章
[Feng Zhen-ru]的文章
[Lu Hai-ying]的文章
百度学术
百度学术中相似的文章
[Bai Li]的文章
[Feng Zhen-ru]的文章
[Lu Hai-ying]的文章
必应学术
必应学术中相似的文章
[Bai Li]的文章
[Feng Zhen-ru]的文章
[Lu Hai-ying]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。